M. Moriyama et al., Clinico-epidemiological study of GBV-C/HGV infection in Tokyo metropolitan, and Nanjing and Yanbian cities in the People's Republic of China, HEPATOL RES, 21(3), 2001, pp. 268-279
In the present study, we compared the molecular epidemiology of GBV-C/HGV c
o-infection and the clinical profiles in patients diagnosed with either typ
e B or type C hepatitis virus infection from Nanjing in Southeast China and
Yanbian in Northeast China, with those at the Nihon University Hospital in
Tokyo. The patients included 97 men in Nanjing, 66 men and women in Yanbia
n, and 249 men and women at the Nihon University Hospital. GBV-C/HGV RNA wa
s detected using reverse transcriptase polymerase chain reaction as describ
ed by Abe et al. The prevalence of GBV-C/HGV co-infection in Nanjing, Yanbi
an, and Tokyo was 18.8, 23.3, and 3.5% in type B liver diseases, respective
ly, and 3.6, 11.1, 7.3% in type C liver diseases, respectively. A compariso
n of background factors between GBV-C/HGV RNA-positive and -negative patien
ts revealed no significant differences in any parameter between Nanjing, Ya
nbian, and Tokyo. A phylogenic tree analysis of nucleotide sequences showed
that the Nanjing strain was closely related to the Shanghai, Hong Kong, an
d Tokyo isolates, while the Yanbian isolate was closely related to the Kore
an, Mongolia, and Tokyo strains. These isolates were classified to the East
Asian type of genotype 3. The results of the phylogenic tree analysis sugg
ests that the GBV-C/HGV isolates from China and Japan have a common origin.
Therefore, the prevalence of GBV-C/HGV infection may be geographically det
ermined, irrespective of racial differences. (C) 2001 Elsevier Science Irel
and Ltd. All rights reserved.